Literature DB >> 8929295

Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients.

J Dubois1, L Garel, H Patriquin, K Paradis, S Forget, D Filiatrault, A Grignon, P Russo, D St-Vil.   

Abstract

Hereditary tyrosinemia type 1, a common genetic disorder in the province of Quebec, is characterized by a deficiency of fumarylacetoacetate hydrolase. In this autosomal recessive disorder of tyrosine metabolism, the accumulation of succinylacetone leads to neurologic crises, acute and chronic liver failure, complex renal tubulopathy, rickets and a hemorrhagic syndrome. Liver trans- plantation has dramatically modified the spontaneous course of this lethal disease. The present paper describes the imaging features of tyrosinemia in 30 patients followed from 1980 to 1995 at Hôpital Sainte-Justine, Montreal, Canada.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929295     DOI: 10.1007/bf03178035

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  16 in total

1.  Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Authors:  K Paradis; A Weber; E G Seidman; J Larochelle; L Garel; C Lenaerts; C C Roy
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 2.  Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

Authors:  T E Starzl; B J Zitelli; B W Shaw; S Iwatsuki; J C Gartner; R D Gordon; J J Malatuck; I J Fox; A H Urbach; D H Van Thiel
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

3.  The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

Authors:  A G Weinberg; C E Mize; H G Worthen
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

4.  Experience with 37 infants with tyrosinemia.

Authors:  J Larochelle; A Mortezai; M Belanger; M Tremblay; J C Claveau; G Aubin
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

5.  Neurologic crises in hereditary tyrosinemia.

Authors:  G Mitchell; J Larochelle; M Lambert; J Michaud; A Grenier; H Ogier; M Gauthier; J Lacroix; M Vanasse; A Larbrisseau
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

6.  Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity.

Authors:  Y Labelle; D Phaneuf; B Leclerc; R M Tanguay
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

7.  Hepatic regenerating nodules in hereditary tyrosinemia.

Authors:  D L Day; J G Letourneau; B T Allan; H L Sharp; N Ascher; L P Dehner; W M Thompson
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

8.  Early liver transplantation is indicated for tyrosinemia type I.

Authors:  D K Freese; M Tuchman; S J Schwarzenberg; H L Sharp; J M Rank; J R Bloomer; N L Ascher; W D Payne
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-07       Impact factor: 2.839

9.  Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean.

Authors:  M De Braekeleer; J Larochelle
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

10.  Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15.

Authors:  D Phaneuf; Y Labelle; D Bérubé; K Arden; W Cavenee; R Gagné; R M Tanguay
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  2 in total

1.  Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.

Authors:  Hanaa El-Karaksy; Mona Fahmy; Mona El-Raziky; Nehal El-Koofy; Rokaya El-Sayed; Mohamed S Rashed; Hasan El-Kiki; Ahmad El-Hennawy; Nabil Mohsen
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Revisiting hereditary tyrosinemia Type 1-spectrum of radiological findings.

Authors:  Sana Shaikh; Asma Qureshi; Syed Mohammad Faiq
Journal:  BJR Case Rep       Date:  2018-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.